Human NT-proBNP(N-Terminal Pro-Brain Natriuretic Peptide) ELISA Kit
中文名称:人氨基端前脑钠素(NT-proBNP)酶联免疫吸附测定试剂盒
别称:
NT-Pro-BNP
Price:
Size:
96T
48T
96T*5
- 反应性: Human
- 检测范围: 0.16-10 ng/mL
- 灵敏度: 0.09 ng/mL
产品应用 | ELISA |
检测原理 | 本试剂盒采用双抗体夹心ELISA法。用抗人NT-proBNP抗体包被于酶标板上,实验时样品(或标准品)中的人NT-proBNP会与包被抗体结合。后依次加入生物素化的抗人NT-proBNP抗体和辣根过氧化物酶标记的亲和素,抗人NT-proBNP抗体与结合在包被抗体上的人NT-proBNP结合,生物素与亲和素特异性结合而形成免疫复合物,游离的成分被洗去。加入显色底物(TMB),TMB在辣根过氧化物酶的催化下呈现蓝色,加终止液后变成黄色。用酶标仪在450 nm波长处测OD值,NT-proBNP浓度与OD450值之间呈正比,通过绘制标准曲线计算出样品中NT-proBNP的浓度。 |
反应类型 | Sandwich-ELISA |
规格 |
96T
/ 48T
/ 96T*5
|
反应时间 | 3.5h |
反应性 | Human |
检测方法 | 比色法 |
检测范围 | 0.16-10 ng/mL |
灵敏度 | 0.09 ng/mL |
样本体积 | 100μL |
样本类型 | 血清,血浆,细胞上清,细胞提取液体,组织匀浆等其他生物体液 |
特异性 | 可检测样本中的人NT-proBNP,且与其它类似物无明显交叉反应 |
精密度 | 板内,板间变异系数均<10% |
回收率 | 80%-120% |
储存条件 | 2-8℃/-20℃ |
数据处理 |
-
Discriminative Value of Serum Irisin in Prediction of Heart Failure with Different Phenotypes among Patients with Type 2 Diabetes Mellitus
IF: 7.666 -
Compound Danshen Dripping Pill inhibits doxorubicin or isoproterenol-induced cardiotoxicity
IF: 6.53 -
The Association of Glucose Control with Circulating Levels of Red Blood Cell-Derived Vesicles in Type 2 Diabetes Mellitus Patients with Atrial Fibrillation
IF: 6.208Journal:INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES -
Incremental Predictive Value of Longitudinal Axis Strain and Late Gadolinium Enhancement Using Standard CMR Imaging in Patients with Aortic Stenosis
IF: 5.688 -
The Impact of SGLT2 Inhibitor Dapagliflozin on Adropin Serum Levels in Men and Women with Type 2 Diabetes Mellitus and Chronic Heart Failure
IF: 4.757Journal:Biomedicines -
The Effect of SGLT2 Inhibitor Dapagliflozin on Serum Levels of Apelin in T2DM Patients with Heart Failure
IF: 4.757 -
Serum Levels of Irisin Predict Cumulative Clinical Outcomes in Heart Failure Patients With Type 2 Diabetes Mellitus
IF: 4.566 -
Interplay between Myokine Profile and Glycemic Control in Type 2 Diabetes Mellitus Patients with Heart Failure
IF: 3.992Journal:Diagnostics -
Discriminative Utility of Apelin-to-NT-Pro-Brain Natriuretic Peptide Ratio for Heart Failure with Preserved Ejection Fraction among Type 2 Diabetes Mellitus Patients
IF: 3.948Journal:Journal of Cardiovascular Development and Disease -
Impact of Lipophilic Versus Hydrophilic Statins on the Clinical Outcome and Biomarkers of Remodeling in Heart Failure Patients: A Prospective Comparative Randomized Study
IF: 3.74Journal:BRITISH JOURNAL OF CLINICAL PHARMACOLOGY